Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Classical hematology 1Breast 1

Conditions

Nasopharyngeal Carcinoma 71Nasopharyngeal Neoplasms 25Head and Neck Neoplasms 25Squamous Cell Carcinoma of Head and Neck 18Neoplasm Metastasis 14Carcinoma, Non-Small-Cell Lung 11Recurrence 9Salivary Gland Neoplasms 7Ovarian Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Small Cell Lung Carcinoma 5Prostatic Neoplasms 5Neoplasms 5Melanoma 5Colorectal Neoplasms 5Breast Neoplasms 5Triple Negative Breast Neoplasms 4Sarcoma 4Lung Neoplasms 4Esophageal Neoplasms 4Urinary Bladder Neoplasms 3Thyroid Neoplasms 3Laryngeal Diseases 3Epstein-Barr Virus Infections 3Colonic Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Osteosarcoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2

Interventions

apixaban 1Gemcitabine 1Enoxaparin 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Venous Thromboembolism × Gemcitabine × Head & Neck × Clear all
NCT01325558 2016-07-15

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Altor BioScience

Phase 1 Completed
30 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡